Lexaria Bioscience Corp LEXX

Alternate Symbol(s): LEXXW

Healthcare

Lexaria Bioscience Corp. is a Canada-based biotechnology company. The Company is engaged in pursuing the enhancement of the bioavailability of a diverse and a range of active pharmaceutical ingredients (API) using DehydraTECH, its patented proprietary drug delivery technology. The Company’s patented drug delivery technology, DehydraTECH, is designed to improve the way active molecules enter the bloodstream upon oral ingestion. DehydraTECH has also demonstrated enhanced delivery of certain active molecules into brain tissue. The Company has also developed DehydraTECH formulations for other applications demonstrating bio-absorption when administered intraorally and topically. It operates through two segments: Intellectual Property and Products. It also operates a licensed in-house research laboratory and holds an intellectual property portfolio with 35 patents granted and many patents pending worldwide. Its subsidiaries include Lexaria CanPharm ULC, and Lexaria CanPharm Holdings Corp.

NDAQ:LEXX - Post by User

Lexaria Bioscience Corp > We have more reason to be long

<< Previous

Bullboard Posts

Next >>

Comment by Yowza123on Feb 06, 2021 7:00pm

101 Views

Post# 32494340

RE:We have more reason to be long

Lexaria is a great company but if your company owns 800K shares then why are there no forms submitted as required by law for your company showing on the SEC filings?
https://ir.lexariabioscience.com/sec-filings/all-sec-filings
I only see one for 5% of the company, none for your 15%!!

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments